“…The PEO-PPO-PEO block copolymer vesicles with high stability should provide various opportunities for material, biological and medical applications such as drug delivery system [25]. Thus, several approaches have been attempted to improve the stability of PEO-PPO-PEO block copolymer vesicles, polymer vesicles (polymersomes) and nonionic surfactant vesicles (noisomes): utilization of hydrophobic block copolymers such as poly(ethylene oxide)-poly(ethyl ethylene) [26], poly(ethylene oxide)-cholesterol [27], poly(ethylene oxide)-poly(propylene oxide)-poly(lactic acid) [28] or mixing of polymers, surfactants and hydrophobic components, for example, Pluronic P123/sodium dodcyl sulfate/NaF mixture [29], Pluronic L121/Pluronic P85/pentaerythritol tetraacrylate mixture [30], a poly(ethylene glycol)/Tween 80/Span 80 mixture [31][32][33][34][35], nonionic surfactant/cholesterol mixture [36,37], poly(ethylene glycol)-b-poly(sodium methacrylate)/cationic surfactant mixture [38], poly(ethylene glycol)-b-poly(acrylic acid)/azobenzene-containing surfactant mixture [39] and poly(ethylene oxide)-b-poly(1,2-butylene oxide)/ionic surfactant mixture [40].…”